← All trials
NCT01246869
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 27, 2013
- Primary completion
- May 3, 2014
- Completion date
- Jan 20, 2023
- First posted
- Nov 23, 2010
- Last posted
- Mar 20, 2023
- Enrollment
- 2
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of UtahLead sponsor
- University of UtahOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.